US lawmakers debate China strategy; balance security, civil liberties
Washington, June 27
US lawmakers and national security experts this week agreed that China poses one of America's most significant strategic challenges, but differed over how Washington should respond without undermining civil liberties, academic openness and the country's ability to attract global talent.
The debate unfolded during a hearing of the House Select Committee on the Chinese Communist Party, where witnesses discussed issues ranging from technology theft and foreign investment to university research, counter-intelligence and immigration.
Former Acting Director of the Defence Intelligence Agency David Shedd argued that the United States needed to do more to protect sensitive technologies while avoiding excessive government regulation of private industry.
Shedd voiced concern over foreign acquisitions of American companies with valuable intellectual property, saying legal commercial transactions could sometimes achieve the same strategic objectives as cyber espionage if they transferred sensitive technologies to China. He said greater scrutiny of such investments was needed.
Lawmakers also questioned whether Chinese companies identified by the US government as national security risks should continue to benefit from American patent protections.
Asked whether such firms should retain access to US patents, Shedd replied: "The answer is absolutely not," arguing that allowing them to use those rights against American companies created a serious contradiction.
Witnesses also highlighted concerns about research security at American universities. Michael Lucci said some US institutions had partnered with Chinese organisations linked to the country's military despite receiving American government research funding. He described such arrangements as a growing national security concern.
John C. Yang, president and executive director of Asian Americans Advancing Justice, argued that protecting national security and preserving America's scientific leadership should not be treated as competing goals.
He pointed to new federal disclosure standards for research grants as a better way to strengthen transparency while avoiding the mistakes of earlier programmes that disproportionately affected researchers of Chinese origin. Yang also called for immigration reforms that would encourage highly skilled scientists and researchers to remain in the United States.
Several lawmakers also questioned recent changes affecting federal counter-intelligence capabilities, expressing concern that reducing dedicated resources to combat foreign influence could weaken Washington's response to China's expanding intelligence operations. Shedd said scaling back such capabilities would be "a mistake", although he added that existing programmes should also be evaluated for effectiveness.
Throughout the hearing, members of both parties agreed that China remains the United States' principal long-term strategic competitor. Their debate centred less on whether Beijing poses a threat than on how best to protect American technology, research and national security while maintaining the openness that has long underpinned US scientific and economic leadership.
— IANS
Reader Comments
I appreciate that they're trying to be careful about not targeting Chinese researchers. But let's be honest - India's experience shows that when you have a strategic competitor like China, you can't afford to be too open. We've seen how they use economic partnerships and academic exchanges to gain access to sensitive technologies. The US should learn from our mistakes with infrastructure projects in Sri Lanka and Nepal.
As someone with Indian colleagues in Silicon Valley, I can see both sides. The openness of American universities is what made them world-class, and targeting Chinese researchers could backfire. But at the same time, we can't ignore the reality of state-sponsored IP theft. India's IT sector developed partly because of this openness - we need to be smart about it, not paranoid.
The patent issue is huge. Indian pharmaceutical companies have been fighting this battle for years - Chinese firms patent our traditional knowledge and then use those patents against us. If the US can't even protect its own IP system, what hope do developing countries have? Shedd is absolutely right about revoking patent protections for Chinese state-linked entities.
Here's my concern: every time there's a security scare, governments overreact and target minorities. The Chinese-American community is already anxious. India's had similar issues with targeting of Muslims after security incidents. Yang is right - we need transparency without creating a hostile environment for researchers. Otherwise, the best talent goes to other countries.
Living in India, I watch this debate with mixed feelings. On one hand, we see China snapping up assets globally. On the other, the
We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.